Ergoloid Mesylates

Title: Ergoloid Mesylates
CAS Registry Number: 8067-24-1
CAS Name: Dihydroergotoxine monomethanesulfonate (salt)
Additional Names: co-dergocrine mesylate
Manufacturers' Codes: CCK-179
Trademarks: Circanol (3M); Coristin (San Carlo); Dacoren (Nattermann); DCCK (Rentschler); Decril (Mediolanum); Dulcion (Dulcis); Ergodesit (Graf); Ergohydrin (Streuli); Ergoplus (Formosan); Hydergine (Sandoz); Lysergin (Toa Eiyo); Novofluen (Engelhard KG); Orphol (Sanofi); Pérénan (Sanofi Winthrop); Progeril (Midy); Redergin (Lek); Sponsin (Farmasan); Trigot (BMS)
Literature References: Hydrogenated ergot alkaloids, specifically an equiproportional mixture of dihydroergocornine methanesulfonate, dihydroergocristine methanesulfonate and a- and b-dihydroergocryptine methanesulfonate in the ratio of 1.5-2.5:1. Neuropharmacological investigations: D. M. Loew et al., Postgrad. Med. J. 52, Suppl. 1, 40 (1976).
Derivative Type: Dihydroergocristine methanesulfonate
CAS Registry Number: 24730-10-7
Trademarks: Decme (Spitzner); Defluina (Simes); Enirant (Desitin); Insibrin (Byk-Liprandi); Nehydrin (TAD); Simactil (Rorer); Unergol (Poli)
Molecular Formula: C36H45N5O8S
Molecular Weight: 707.84
Percent Composition: C 61.09%, H 6.41%, N 9.89%, O 18.08%, S 4.53%
Therap-Cat: a-Adrenergic blocker (treatment of impaired mental function in the elderly).
Keywords: a-Adrenergic Blocker.
Ergometrinine Ergonovine Ergosine Ergostane Ergostanol

Ergoloid
Ergoloid skeletal.svg
Combination of
Dihydroergocristine Ergot alkaloid
Dihydroergocornine Ergot alkaloid
alpha-Dihydroergocryptine Ergot alkaloid
beta-Dihydroergocryptine Ergot alkaloid
Clinical data
Pregnancy cat. Contraindicated
Legal status Prescription only
Routes Oral, parenteral
Identifiers
CAS number 8067-24-1 YesY
ATC code C04AE01
DrugBank DB01049
ChEBI CHEBI:59756 N
 N (what is this?)  (verify)

Ergoloid mesylates (USAN), co-dergocrine mesilate (BAN) or dihydroergotoxine mesylate, trade name Hydergine, is a mixture of the methanesulfonate salts of three dihydrogenated ergot alkaloids (dihydroergocristine, dihydroergocornine, and alpha- and beta-dihydroergocryptine).

It was developed by Albert Hofmann (the inventor of LSD) for Sandoz (now part of Novartis).